Citius Pharmaceuticals Inc. (CTXR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Pharmaceuticals In...

    NASDAQ: CTXR · Real-Time Price · USD
    1.37
    0.04 (3.01%)
    At close: Oct 03, 2025, 3:59 PM
    1.39
    1.46%
    After-hours: Oct 03, 2025, 07:20 PM EDT

    Citius Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 209.61K 194.32K 179.68K 164.87K
    Gross Profit
    		 -209.61K -194.32K -179.68K -164.87K
    Operating Income
    		 -42M -36.73M -33.32M -23.53M
    Interest Income
    		 758K 1.18M 251.4K 261.82K
    Pretax Income
    		 -38.85M -31.97M -33.06M -23.05M
    Net Income
    		 -39.14M -32.54M -33.64M -23.13M
    Selling & General & Admin
    		 18.25M 21.91M 15.66M 11.29M
    Research & Development
    		 11.91M 14.82M 17.66M 12.24M
    Other Expenses
    		 11.84M n/a n/a n/a
    Operating Expenses
    		 42M 36.73M 33.32M 23.53M
    Interest Expense
    		 n/a n/a 251.4K 10.84K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 41.99M 36.73M 33.32M 23.53M
    Income Tax Expense
    		 576K 576K 576K n/a
    Shares Outstanding (Basic)
    		 11.59M 9.74M 9.74M 7.24M
    Shares Outstanding (Diluted)
    		 11.59M 10.09M 9.74M 7.24M
    EPS (Basic)
    		 -5.97 -5.57 -5.76 -5.64
    EPS (Diluted)
    		 -5.97 -5.57 -5.76 -5.64
    EBITDA
    		 -38.64M -31.77M -32.88M -22.88M
    EBIT
    		 -38.85M -31.97M -33.06M -23.04M
    Depreciation & Amortization
    		 209.61K 194.32K 179.68K 164.87K

    Add to Watchlist